Pharmacokinetics of new oral hepatitis C antiviral drugs

Author： Vispo Eugenia Barreiro Pablo Soriano Vicente

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.1, 2013-01, pp. : 5-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4269-4270

Blackwell Publishing

Access to resources Recommend Favorite

Direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4268-4269

Blackwell Publishing

Access to resources Recommend Favorite

Treatment failure with new hepatitis C drugs

By Soriano Vincent Vispo Eugenia Poveda Eva Labarga Pablo Barreiro Pablo

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 313-323

Informa Healthcare

Access to resources Recommend Favorite

The Role of Organic Transporters in Pharmacokinetics and Nephrotoxicity of Newer Antiviral Therapies for HIV and Hepatitis C

Current Drug Metabolism, Vol. 16, Iss. 4, 2015-01 ,pp. : 322-331

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Viral Therapies for Hepatitis C Virus Infection: Current Options and Evolving Candidate Drugs

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 150-161

Bentham Science Publishers

Access to resources Recommend Favorite